Physician profile
Ivan E Terrero
NPI 1720066673
$604.24
in general payments reported to CMS, 2019-2025
10 companies · $65.76 in 2025
The $65.76 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.12 · 2020: $11.37 · 2021: $120 · 2022: $133 · 2023: $135 · 2024: $93.27 · 2025: $65.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181 · Gift: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.36 |
| Gift | $112.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orapharma, A Division of Bausch Health US, LLC | $201.66 | 2021-2025 | Arestin |
| Ultradent Products INC | $136.11 | 2019-2023 | Opalescence |
| Biohorizons Implant Systems INC. | $76.74 | 2021-2022 | |
| Straumann USA LLC | $64.21 | 2024-2025 | |
| Align Technology, INC. | $49.12 | 2019-2024 | Invisalign |
| Dentsply Sirona INC | $22.33 | 2023 | Imaging Software |
| Pacira Pharmaceuticals Incorporated | $16.91 | 2022 | |
| Implant Direct Sybron International LLC | $13.38 | 2021 | |
| Voco America INC. | $12.41 | 2025 | Meron Plus Qm, Grandio So Heavy Flow, Admira Fusion X-Tra |
| Philips North America LLC | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Terrero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.